Figure 2 | Scientific Reports

Figure 2

From: Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer

Figure 2

Chemopreventive effects of DFMO, Rosuvastatin, or combination of low-dose DFMO plus Rosuvastatin on (A) azoxymethane (AOM)-induced colon Adenocarcinoma multiplicity, (B) Adenocarcinoma incidence, and (C) Adenoma Multiplicity in male F344 rats. Data values are means ±SEM of 30 animals per treatment group with Welch’s correction. Control and treated groups are significantly different from one another (P < 0.05).

Back to article page